It has previously been unclear whether the accumulation of advanced glycation end products, which can be measured using skin autofluorescence (SAF), has a significant role in diabetic kidney disease (DKD), including glomerular injury and tubular injury. This study was therefore carried out to determine whether SAF correlates with the progression of DKD in people with type 2 diabetes (T2D). In 350 Japanese people with T2D, SAF values were measured using an AGE Reader, and both urine albumin-to-creatinine ratio (uACR), as a biomarker of glomerular injury, and urine liver-type fatty acid-binding protein (uLFABP)-to-creatinine ratio (uL-FABPCR), as a biomarker of tubular injury, were estimated as indices of the severity of DKD. Significant associations of SAF with uACR ( < 0.01), log-transformed uACR ( < 0.001), uL-FABPCR ( < 0.001), and log-transformed uL-FABPCR ( < 0.001) were found through a simple linear regression analysis. Although SAF was positively associated with increasing uL-FABPCR ( < 0.05) and increasing log-transformed uL-FABPCR ( < 0.05), SAF had no association with increasing uACR or log-transformed uACR after adjusting for clinical confounding factors. In addition, the annual change in SAF showed a significant positive correlation with annual change in uL-FABPCR regardless of confounding factors ( = 0.026). In conclusion, SAF is positively correlated with uL-FABP but not with uACR in people with T2D. Thus, there is a possibility that SAF can serve as a novel predictor for the development of diabetic tubular injury.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669246PMC
http://dx.doi.org/10.3390/biomedicines11113020DOI Listing

Publication Analysis

Top Keywords

tubular injury
16
saf
9
skin autofluorescence
8
liver-type fatty
8
fatty acid-binding
8
acid-binding protein
8
people type
8
type diabetes
8
glomerular injury
8
people t2d
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!